Aspirin for elevated lipoprotein(a) in primary prevention: evidence mounting

European Heart Journal 2026

View at publisher
Authors: Paul A Lacaze, Stephen J Nicholls
DOI: 10.1093/eurheartj/ehag161
Cited by: 1
References: 15

Abstract

Evidence is mounting that aspirin may be effective for the primary prevention of atherosclerotic cardiovascular disease in individuals with elevated lipoprotein(a) levels

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Antiplatelet Therapy and Cardiovascular Diseases Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
European Heart Journal
Publisher
Oxford University Press (OUP)
Volume
47
Issue
34
Pages
4802–4805
Publication date
16 February 2026
Language
EN